HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wijnand Helfrich Selected Research

Bombesin

10/2013Application of (99m)Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7-14) SPECT/CT in prostate cancer patients: a first-in-man study.
2/2013Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer.
1/2013An update of radiolabeled bombesin analogs for gastrin-releasing peptide receptor targeting.
8/2011(99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wijnand Helfrich Research Topics

Disease

50Neoplasms (Cancer)
07/2023 - 04/2002
12Prostatic Neoplasms (Prostate Cancer)
04/2021 - 07/2009
9Carcinoma (Carcinomatosis)
01/2023 - 03/2004
7Melanoma (Melanoma, Malignant)
03/2022 - 11/2010
5Ovarian Neoplasms (Ovarian Cancer)
07/2023 - 01/2010
3Neoplasm Metastasis (Metastasis)
01/2022 - 07/2009
3Ovarian Epithelial Carcinoma
10/2018 - 01/2010
2Triple Negative Breast Neoplasms
03/2016 - 01/2016
2Rheumatoid Arthritis
09/2014 - 01/2011
2Infections
06/2013 - 12/2008
2Brain Neoplasms (Brain Tumor)
07/2007 - 05/2006
2Lymphoma (Lymphomas)
02/2007 - 04/2005
2Leukemia
04/2006 - 04/2005
2T-Cell Leukemia (Leukemia, T Cell)
04/2006 - 04/2005
1Photophobia (Light Sensitivity)
02/2024
1Glioblastoma (Glioblastoma Multiforme)
07/2023
1Cytokine Release Syndrome
01/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019
1Lung Neoplasms (Lung Cancer)
01/2019
1Bites and Stings (Sting)
01/2019
1Breast Neoplasms (Breast Cancer)
03/2016
1Sarcoma (Soft Tissue Sarcoma)
01/2015
1Colorectal Neoplasms (Colorectal Cancer)
01/2015

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
02/2024 - 03/2004
16AntigensIBA
03/2022 - 03/2004
15AntibodiesIBA
07/2023 - 04/2002
9Epithelial Cell Adhesion MoleculeIBA
07/2023 - 03/2004
8Immunoglobulin FragmentsIBA
01/2023 - 04/2006
8LigandsIBA
10/2017 - 03/2005
7Peptides (Polypeptides)IBA
07/2023 - 07/2009
5ErbB Receptors (EGF Receptor)IBA
01/2019 - 03/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 04/2002
5Bombesin Receptors (Bombesin Receptor)IBA
10/2013 - 07/2009
4RadiopharmaceuticalsIBA
01/2021 - 08/2011
4TNF-Related Apoptosis-Inducing LigandIBA
08/2016 - 03/2004
4Monoclonal AntibodiesIBA
01/2015 - 03/2005
4BombesinIBA
10/2013 - 08/2011
3beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
07/2023 - 08/2021
3Adenosine (Adenocard)FDA LinkGeneric
07/2023 - 08/2021
3Adenosine Triphosphate (ATP)IBA
07/2023 - 08/2021
3Surface Antigens (Surface Antigen)IBA
01/2023 - 03/2004
3chondroitin sulfate proteoglycan 4IBA
11/2019 - 01/2016
3Rituximab (Mabthera)FDA Link
01/2019 - 08/2006
3VaccinesIBA
10/2018 - 01/2010
3TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
02/2016 - 03/2004
2Immune Checkpoint InhibitorsIBA
01/2023 - 11/2019
2Antigen-Antibody Complex (Immune Complex)IBA
01/2023 - 04/2002
2Cytotoxins (Cytolysins)IBA
01/2023 - 05/2006
2AzidesIBA
04/2021 - 08/2020
2Alkynes (Acetylenes)IBA
04/2021 - 08/2020
2Bispecific AntibodiesIBA
01/2019 - 05/2008
2Glycoproteins (Glycoprotein)IBA
06/2017 - 08/2008
2Immunoglobulin G (IgG)IBA
01/2015 - 04/2002
2Immunotoxins (Immunotoxin)IBA
10/2014 - 05/2013
2temoporfinIBA
10/2014 - 05/2012
2Radioisotopes (Radionuclides)IBA
06/2014 - 08/2012
2Technetium (Technetium 99m)IBA
10/2013 - 08/2011
2bombesin (7-14)IBA
10/2013 - 08/2011
2tricineIBA
10/2013 - 08/2011
2rimcazoleIBA
09/2013 - 11/2010
2Death Domain ReceptorsIBA
05/2013 - 02/2007
2Gefitinib (Iressa)FDA Link
08/2006 - 03/2005
2Bortezomib (Velcade)FDA Link
08/2006 - 04/2006
1SolitomabIBA
01/2023
1EnzymesIBA
01/2023
1Fluorescein (Funduscein)FDA LinkGeneric
03/2022
1IsotopesIBA
03/2022
1Cancer VaccinesIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA
01/2022
15'-Nucleotidase (5' Nucleotidase)IBA
08/2021
1Androgen Receptors (Androgen Receptor)IBA
01/2021
1enzalutamideIBA
01/2021
1Viral ProteinsIBA
01/2020
1Programmed Cell Death 1 ReceptorIBA
11/2019
1blinatumomabIBA
01/2019
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019
1durvalumabIBA
01/2018
1Fluorescein-5-isothiocyanate (FITC)IBA
10/2017
1Granzymes (Granzyme)IBA
03/2016
1human ERBB2 proteinIBA
01/2016
1Estrogens (Estrogen)FDA Link
01/2016
1ProgesteroneFDA LinkGeneric
01/2016
1CalreticulinIBA
01/2015
1Therapeutic UsesIBA
01/2015
1Immunoglobulin Fab FragmentsIBA
01/2015
1Complement System Proteins (Complement)IBA
01/2015
1Galectins (Galectin)IBA
01/2015
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2014
1Photosensitizing Agents (Photosensitizers)IBA
10/2014
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2014

Therapy/Procedure

19Therapeutics
07/2023 - 09/2004
12Immunotherapy
01/2023 - 04/2002
4Drug Therapy (Chemotherapy)
10/2018 - 01/2010
2Computer-Assisted Surgery (Image Guided Surgery)
11/2014 - 06/2014
2Radiotherapy
10/2013 - 05/2006
1Cytoreduction Surgical Procedures
01/2022
1Hyperthermic Intraperitoneal Chemotherapy
01/2022
1Aftercare (After-Treatment)
01/2018
1Photochemotherapy (Photodynamic Therapy)
10/2014